NASDAQ:OPNT - Opiant Pharmaceuticals Price Target & Analyst Ratings

Sign in or create an account to add this stock to your watchlist.
$15.1450 +0.12 (+0.80 %)
(As of 01/18/2019 04:00 PM ET)
Previous Close$15.1450
Today's Range$14.4097 - $15.20
52-Week Range$12.02 - $32.28
Volume17,755 shs
Average Volume24,863 shs
Market Capitalization$57.60 million
P/E Ratio5.15
Dividend YieldN/A
Beta0.69

Analyst Ratings

Opiant Pharmaceuticals (NASDAQ:OPNT) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
1 Wall Street analysts have issued ratings and price targets for Opiant Pharmaceuticals in the last 12 months. Their average twelve-month price target is $42.00, suggesting that the stock has a possible upside of 177.32%. The high price target for OPNT is $42.00 and the low price target for OPNT is $42.00. There are currently 1 buy rating for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 3.003.003.003.00
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $42.00$42.00$42.00$32.00
Price Target Upside: 177.32% upside125.56% upside125.56% upside107.79% upside

Opiant Pharmaceuticals (NASDAQ:OPNT) Consensus Price Target History

Price Target History for Opiant Pharmaceuticals (NASDAQ:OPNT)

Opiant Pharmaceuticals (NASDAQ:OPNT) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
10/4/2018Cantor FitzgeraldSet Price TargetBuy$42.00LowView Rating Details
(Data available from 1/19/2017 forward)
This page was last updated on 1/19/2019 by MarketBeat.com Staff

Featured Article: What is a Swap?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel